Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2026-03-17 @ 5:15 AM
Study NCT ID:
NCT01130818
Status:
COMPLETED
Last Update Posted:
2024-03-01
First Post:
2010-05-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First-in-Human Single Ascending Dose of GLPG0492
Sponsor:
Galapagos NV
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GLPG0492-CL-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None